News

Mobility Saves FB logoExton, Pa (Corporate)- Ability Prosthetics & Orthotics recently endorsed and began actively promoting the results of the American Orthotic & Prosthetic Association’s (AOPA) and the Amputee Coalition’s sponsored research to prove clinical value and economic advantages of providing P&O intervention through the Mobility Saves Lives & Money campaign.

The research was conducted by Dobson DaVanzo & Associates, a health economics and policy consulting firm based in the Washington, D.C. area, whose lead partner is the former director of research for the Medicare program. Drawing from the vast Medicare database, researchers were able to put together a comprehensive picture of the impact of P&O care over time.

The study results show the cost of co-morbidity treatment among those not receiving P&O care exceeds what the cost of care was for comparable patients who received such care.  Researchers found that payers can realize a return on investment on P&O treatment within just 12 to 18 months, an indication that such treatments are highly cost effective.  The cumulative cost of health care for those who received P&O care was lower than it was for those who did not, ranging up to 10 percent for some conditions during the 12- and 18-month windows of time that services were tracked.

“We certainly welcome the hard data,” explains Jeffrey Brandt, CEO & CPO of Ability Prosthetics & Orthotics of Exton, Pennsylvania, which operates 10 patient care offices across 4 states, “The results back up the intuitive thought that if folks are mobile, they are walking, they are independent.  They might be working and contributing to many more aspects of society.  We’ll (Ability) certainly be making the case to our payers and referral sources, that mobility, along with new outcome measures, generate quantitative data in which to support P&O treatment.”

For more information and access to the full study, please visit, www.mobilitysaves.org

Mobility Saves Banner_728x90

 

Comments are closed.